GSK appoint Emma Walmsley as CEO after Andrew Witty retires after almost ten years in post



BRITISH drugs giant GlaxoSmithKline announced today that it had appointed Emma Walmsley, the head of its consumer healthcare unit, as its new chief executive to succeed Sir Andrew Witty, who is retiring.

Source: Daily Express :: Finance Feed http://ift.tt/2czVi7j

Share this

Related Posts

Previous
Next Post »